Oxidative remodeling in pressure overload induced chronic heart failure

European Journal of Heart Failure

Volumn 9, Issue 5, 2007, Pages 450-457

  Henderson, Brooke C ^a   Tyagi, Neetu ^a   Ovechkin, Alexander ^a   Kartha, Ganesh K ^a   Moshal, Karni S ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Collagen; eNOS; iNOS; MMP; SOD; Thioredoxin

Indexed keywords

ANTIOXIDANT; COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; SUPEROXIDE DISMUTASE; THIOREDOXIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INDUCTION; GENE MUTATION; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART STRESS; HISTOLOGY; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; WESTERN BLOTTING; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; AORTIC VALVE STENOSIS; BLOOD PRESSURE; BLOTTING, WESTERN; CHRONIC DISEASE; COLLAGEN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ELASTIN; ELECTROCARDIOGRAPHY; ENZYME ACTIVATION; HEART FAILURE, CONGESTIVE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RESEARCH DESIGN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34147116732     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.12.008     Document Type: Article

References (30)

1. Cardiovascular Disease and Oxidative Stress. 1998-2002, Great Smokies Diagnostic Laboratory.
2. MacKenna D., Summerour S.R., and Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 46 2 (2000) 257-263
3. Ungvari Z., et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23 3 (2003) 418-424
4. Thomas J. Oxidative stress: including gluthathione, a peptide for cellular defense against oxidative stress (1999), Iowa State University
5. Kishimoto C., et al. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 65 6 (2001) 491-494
6. Akhter S.A., et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280 5363 (1998) 574-577
7. Byrne J.A., et al. Oxidative stress and heart failure. Arch Mal Coeur Vaiss 96 3 (2003) 214-221
8. D'Armiento J. Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction. Trends Cardiovasc Med 12 3 (2002) 97-101
9. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13 7 (1989) 1637-1652
10. Tyagi S.C., et al. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem 63 2 (1996) 185-198
11. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 31 (1999) 21491-21494
12. Springman E.B., et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A 87 1 (1990) 364-368
13. Nagase H. Zinc metalloproteinases in health and disease (1996), Taylor and Francis London 153-204
14. Tyagi S.C., et al. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J Mol Cell Cardiol 27 10 (1995) 2177-2189
15. Tyagi S.C., et al. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physiol 176 2 (1998) 374-382
16. Mujumdar V.S., and Tyagi S.C. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens 17 2 (1999) 261-270
17. Hunt M.J., et al. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol 283 2 (2002) L239-L245
18. Tyagi S.C., Ratajska A., and Weber K.T. Myocardial matrix metalloproteinase(s): localization and activation. Mol Cell Biochem 126 1 (1993) 49-59
19. Peterson J.T., et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103 18 (2001) 2303-2309
20. Siwik D.A., Pagano P.J., and Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280 1 (2001) C53-C60
21. Liu X., et al. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 130 1 (1995) 227-237
22. Tyagi S.C., Smiley L.M., and Mujumdar V.S. Homocyst(e)ine impairs endocardial endothelial function. Can J Physiol Pharm 77 12 (1999) 950-957
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
24. Kameda K., et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J 24 24 (2003) 2180-2185
25. Moshal K.S., et al. Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol 288 6 (2005) H2770-H2777
26. Takimoto E., et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. Clin Investig 115 5 (2005) 1221-1231
27. Kojda G., and Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43 3 (1999) 562-571
28. Ma Q.L., Xie Y., and Zhang S.D. Effects of trimetazidine on serum oxygen free radicals in congestive heart failure. Hunan Yi Ke Da Xue Xue Bao 27 6 (2002) 527-529
29. Cannella G., et al. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 30 5 (1997) 659-664
30. Rajagopalan S., et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98 11 (1996) 2572-2579